New combo therapy shows promise for Tough-to-Treat bile duct cancer
Disease control
Ongoing
This study tests whether adding the experimental drug CTX-009 to standard chemotherapy (paclitaxel) helps adults with advanced bile duct, gallbladder, or ampullary cancer that has worsened after one prior treatment. About 168 participants will be randomly assigned to receive eith…
Phase: PHASE2, PHASE3 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC